KBRA Assigns Preliminary Ratings to J.P. Morgan Mortgage Trust 2022-INV3 (JPMMT 2022-INV3)
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to 24 classes of mortgage pass-through certificates from J.P….
News
Orphazyme A/S has filed for voluntary delisting of ADSs
Orphazyme A/SCompany announcementNo. 12/2022www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, March 21, 2022 – Orphazyme A/S…
Statera Biopharma Announces Proposed Underwritten Public Offering
FORT COLLINS, Colo., March 21, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
SeqLL Announces Formation of Scientific Advisory Board
BILLERICA, Mass., March 21, 2022 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:…
Viridian Therapeutics Doses First Subject in First-in-Human Clinical Trial Evaluating VRDN-002, a Next Generation IGF-1R Antibody for the Treatment of Thyroid Eye Disease
– VRDN-002 incorporates clinically validated half-life extension technology to support development as a low volume…
AnaptysBio Appoints Daniel Faga As Interim Chief Executive Officer
Company to undergo a strategic portfolio review while continuing to execute on the development of…
DICE Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
On track to deliver topline proof-of-concept data from Phase 1 clinical trial of oral IL-17…
Terns Reports Top-line Results from Phase 1 AVIATION Trial of VAP-1 Inhibitor TERN-201
FOSTER CITY, Calif., March 21, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
TELA Bio Reports Fourth Quarter and Full Year 2021 Financial Results
MALVERN, Pa., March 21, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a…
Adamis Pharmaceuticals Corporation Issues Nationwide Voluntary Recall of SYMJEPI® (epinephrine) Injection for Potential Manufacturing Defect
SYMJEPI Photo 1 SYMJEPI SYMJEPI Photo 2 SYMJEPI SAN DIEGO, March 21, 2022 (GLOBE NEWSWIRE)…
AGTC Announces Proposed Public Offering of Common Stock
GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 21, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2021Â Financial Results and Operational Update
Announces decision to discontinue development of ORIC-101 Company will focus on advancing its three single…
Longboard Pharmaceuticals Announces the Appointment of Highly Accomplished Healthcare Executive Randall Kaye, M.D., as Chief Medical Officer
Philip Perera, M.D., to retire while continuing to participate as an advisor to Longboard Randall…
Voquent is Reinventing Voice-Over
Voquent is Reinventing Voice-Over Voquent is Reinventing Voice-Over 71-75 Shelton Street, London, WC2H 9JQ, United…
LBank Exchange Will List Rubix (RBT) on March 23, 2022
Internet City, Dubai–(Newsfile Corp. – March 21, 2022) – LBank Exchange, a global digital asset…
Visa Collaborates with the Bantu Blockchain Foundation to Educate and Foster Financial Inclusion and Empowerment; in Africa and Other Emerging Economies
Victoria, Seychelles–(Newsfile Corp. – March 21, 2022) – Visa, the world leader in digital payments…
Strategic Storage Trust VI’s $1.0 Billion Initial Public Offering Declared Effective by the Securities and Exchange Commission
LADERA RANCH, Calif.–(BUSINESS WIRE)–Strategic Storage Trust VI, Inc. (“SST VI”), a public non‐traded real estate…
CF Industries Holdings, Inc. Announces Redemption of Senior Notes Due 2023
DEERFIELD, Ill.–(BUSINESS WIRE)–CF Industries Holdings, Inc. (NYSE: CF) today announced that its wholly owned subsidiary…
atai Life Sciences to Participate in Upcoming March Investor Conferences
NEW YORK, March 21, 2022 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”),…
OSE Immunotherapeutics Receives First Notice of Allowance for a US Patent Covering Anti-PD1 Monoclonal Antibody OSE-279 And its Use in Cancer Treatment
Issued by the United States Patent and Trademark Office A New Protection Covering OSE-279 Until…